Ikgdar®
Brand Name: Ikgdar®
Composition: Rituximab Injection (100 mg/10 ml)
Manufacturer: Emcure® (under license or partnership with Roche)
Product Description
Medical Info
Ikgdar® is a prescription-only targeted biologic therapy containing 100 mg of Rituximab per 10 ml of concentrate for solution for infusion. Marketed by Emcure, this therapeutic monoclonal antibody specifically targets the CD20 antigen found on the surface of normal and malignant B lymphocytes. It is clinically indicated for the management of various hematological malignancies, including Non-Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL), as well as certain autoimmune conditions like Rheumatoid Arthritis. Delivered as a single-dose vial, this medication requires specialized handling, precise dilution, and careful intravenous administration under expert oncological supervision.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
